Sevabertinib Approval Narrows HER2-Mutated NSCLC Use
from TheBrief.Health Hosted by TheBrief.Health
FDA cleared Dexcom Stelo for over-the-counter use in people aged 2 years and older without insulin use, expanding access while leaving clinical outcomes uncertain.
Embed this episode
No transcript yet.
Frequently asked questions
How long is this episode of TheBrief.Health?
This episode is 1 minute long.
When was this TheBrief.Health episode published?
This episode was published on September 24, 2026.
Can I download this TheBrief.Health episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.